FDA Calls Out Dutch Manufacturer for Storage Deficiencies

Drug Industry Daily
A A
The FDA hit Rotterdam, Netherlands-based drugmaker Fagron for inadequate drug product storage and procedures for controlling recalled products at the firm’s Saint Paul, Minn., facility.

To View This Article:

Login

Subscribe To Drug Industry Daily